Production (Stage)
Elevation Oncology, Inc.
ELEV
$0.3817
$0.00150.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.75% | 4.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.87% | -19.56% | |||
| Operating Income | -1.87% | 19.56% | |||
| Income Before Tax | -36.23% | 18.98% | |||
| Income Tax Expenses | -33.33% | -25.00% | |||
| Earnings from Continuing Operations | -36.17% | 18.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -36.17% | 18.98% | |||
| EBIT | -1.87% | 19.56% | |||
| EBITDA | -1.87% | 19.56% | |||
| EPS Basic | -36.09% | 19.00% | |||
| Normalized Basic EPS | -3.81% | 19.03% | |||
| EPS Diluted | -36.09% | 19.00% | |||
| Normalized Diluted EPS | -3.81% | 19.03% | |||
| Average Basic Shares Outstanding | 0.09% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||